Psychopharmacological treatment among adolescents with disabilities: Prevalence and predictors in a nationally representative sample

School Psychology Quarterly

Volumn 30, Issue 3, 2015, Pages 443-455

  Sullivan, Amanda L ^a   Sadeh, Shanna ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Disabilities; Psychopharmacology; Special education

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT;

ADOLESCENT; AUTISTIC DISORDER; COGNITION DISORDERS; COMBINATION DRUG THERAPY; DISABLED PERSON; EDUCATION; HUMAN; INTELLECTUAL DISABILITY; LEARNING DISORDERS; LONGITUDINAL STUDY; REHABILITATION; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; AUTISTIC DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DISABLED PERSONS; DRUG THERAPY, COMBINATION; EDUCATION, SPECIAL; HUMANS; INTELLECTUAL DISABILITY; LEARNING DISORDERS; LONGITUDINAL STUDIES;

EID: 84940892158     PISSN: 10453830     EISSN: 19391560     Source Type: Journal    
DOI: 10.1037/spq0000105     Document Type: Article

References (35)

1. Abrams, L., Flood, J., & Phelps, L. (2006). Psychopharmacology in the schools. Psychology in the Schools, 43, 493-501. http://dx.doi.org/10.1002/pits.20163
2. Beitchman, J. H., Cantwell, D. P., Forness, S. R., Kavale, K. A., Kauffman, J. M., & the American Academy of Child and Adolescent Psychiatry. (1998). Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 37(Suppl), 46S-62S. http://dx.doi.org/10.1097/00004583-199810001-00004
3. Bussing, R., Mason, D. M., Leon, C. E., & Sinha, K. (2003). Agreement between CASA parent reports and provider records of children's ADHD services. The Journal of Behavioral Health Services & Research, 30, 462-469. http://dx.doi.org/10.1007/BF02287433
4. Comer, J. S., Olfson, M., & Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 1001-1010. http://dx .doi.org/10.1016/j.jaac.2010.07.007
5. Cooper, W. O., Arbogast, P. G., Ding, H., Hickson, G. B., Fuchs, D. C., & Ray, W. A. (2006). Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics, 6, 79-83. http://dx.doi.org/10.1016/j.ambp.2005.11.002
6. Curtis, L. H., Masselink, L. E., Østbye, T., Hutchison, S., Dans, P. E., Wright, A., Schulman, K. A. (2005). Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States. Archives of Pediatrics & Adolescent Medicine, 159, 362-366. http://dx.doi.org/10.1001/archpedi.159.4.362
7. Data Accountability Center. (2011). Percentage of students ages 6 through 21 served under IDEA, Part B, as a percentage of population, by disability category and state. Retrieved from https://www .ideadata.org/arc_toc13.asp#partbCC
8. Field, M. J., & Boat, T. F. (Eds.). (2012). Safe and effective medicines for children: Pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Washington, DC: National Academies Press.
9. Gerhard, T., Chavez, B., Olfson, M., & Crystal, S. (2009). National patterns in the outpatient pharmacological management of children and adolescents with autism spectrum disorder. Journal of Clinical Psychopharmacology, 29, 307-310. http://dx.doi .org/10.1097/JCP.0b013e3181a20c8a
10. Graves, S., & Serpell, Z. (2013). Racial differences in medication use in a national sample of children with ADHD enrolled in special education. School Mental Health, 5, 175-182. http://dx.doi.org/10.1007/s12310-013-9105-5
11. Individuals with Disabilities Education Improvement Act of 2004, 20 U.S. C. §§1400 et seq. (2014).
12. Leslie, L. K., Weckerly, J., Landsverk, J., Hough, R. L., Hurlburt, M. S., & Wood, P. A. (2003). Racial/ethnic differences in the use of psychotropic medication in high-risk children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 42, 1433-1442. http://dx .doi.org/10.1097/00004583-200312000-00010
13. Lyons, C. L., Wasserman, G. A., Olfson, M., McReynolds, L. S., Musabegovic, H., & Keating, J. M. (2013). Psychotropic medication patterns among youth in juvenile justice. Administration and Policy in Mental Health and Mental Health Services Research, 40, 58-68. http://dx.doi.org/10.1007/s10488-011-0378-4
14. Mattison, R. E. (1999). Use of psychotropic medications in special education students with serious emotional disturbance. Journal of Child and Adolescent Psychopharmacology, 9, 149-155. http://dx.doi.org/10.1089/cap.1999.9.149
15. McClellan, J., Werry, J., & the American Academy of Child and Adolescent Psychiatry. (2001). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 4S-23S. http://dx.doi.org/10.1097/00004583-200107001-00002
16. Merikangas, K. R., He, J. P., Burstein, M., Swendsen, J., Avenevoli, S., Case, B., Olfson, M. (2011). Service utilization for lifetime mental disorders in U.S. adolescents: Results of the National Comorbidity Survey-Adolescent Suppl. (NCS-A). Journal of the American Academy of Child & Adolescent Psychiatry, 50, 32-45. http://dx.doi.org/10.1016/j.jaac.2010.10.006
17. Merikangas, K. R., He, J. P., Rapoport, J., Vitiello, B., & Olfson, M. (2013). Medication use in US youth with mental disorders. JAMA Pediatrics, 167, 141-148.
18. National Institute of Mental Health. (2012). Mental health medications. Retrieved from http://www.nimh.nih.gov/health/publications/mental-healthmedications/index.shtml
19. Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63,679-685. http://dx.doi.org/10.1001/archpsyc.63.6.679
20. Olfson, M., He, J. P., & Merikangas, K. R. (2013). Psychotropic medication treatment of adolescents: Results from the National Comorbidity Survey-Adolescent Suppl. Journal of the American Academy of Child & Adolescent Psychiatry, 52, 378-388. http://dx.doi.org/10.1016/j.jaac.2012.12.006
21. Pless, C. E., & Pless, I. B. (1995). How well they remember. The accuracy of parent reports. Archives of Pediatrics & Adolescent Medicine, 149, 553-558. http://dx.doi.org/10.1001/archpedi.1995.02170180083016
22. Power, T. J., Eiraldi, R. B., Clarke, A. T., Mazzuca, L. B., & Krain, A. L. (2005). Improving mental health service utilization for children and adolescents. School Psychology Quarterly, 20, 187-205. http://dx.doi.org/10.1521/scpq.20.2.187.66510
23. Roberts, H. J., Floress, M. T., & Ellis, C. R. (2009). Training school psychologists in psychopharmacology consultation. Psychology in the Schools, 46, 827-835. http://dx.doi.org/10.1002/pits.20423
24. Rubin, D. (2013). Conflicting data on psychotropic use by children: Two pieces to the same puzzle. JAMA Pediatrics, 167, 189-190.
25. Rubin, D., Matone, M., Huang, Y.-S., dosReis, S., Feudtner, C., & Localio, R. (2012). Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care. Children and Youth Services Review, 34, 1492-1499. http://dx.doi.org/10.1016/j.childyouth.2012.04.006
26. Schnoes, C., Reid, R., Wagner, M., & Marder, C. (2006). ADHD among students receiving special education services: A national survey. Exceptional Children, 72, 483-496.
27. SRI International. (2000). National Longitudinal Transition Study II (NLTS2): Study design, timeline, and data collection plan. Retrieved from http://www.NLTS2.org/studymeth/NLTS2_design_timeline.pdf
28. SRI International. (2001). National Longitudinal Transitions Study-2 data documentation and dictionaries. Retrieved from http://www.nlts2.org/data_dictionary/data_documentation_dictionary .html
29. SRI International. (2008). Issues in working with a large-scale database. Washington, DC: National Center for Special Education Research.
30. U.S. Department of Education. (n.d.). National longitudinal transition study-2 [Waves restricted data]. Washington, DC: Institute of Education Sciences.
31. U.S. Department of Education. (2012). Thirty-first annual report to Congress on the implementation of the Individuals with Disabilities Education Act. Retrieved from http://www2.ed.gov/about/reports/annual/osep/2009/parts-b-c/31st-idea-arc.pdf
32. Valdes, J., Godard, P., Williamson, C., Van Campen, J., McCracken, M., Jones, R., & Cameto, R. (2006). National Longitudinal Transition Study 2 waves 1 and 2 data documentation and dictionary (Vol. 2). Menlo Park, CA: SRI International.
33. Wagner, M., Kutash, K., Duchnowski, A. J., & Epstein, M. H. (2005). The special education elementary longitudinal study and the national longitudinal transition study: Study designs and implications for children and youth with emotional disturbance. Journal of Emotional and Behavioral Disorders, 13, 25-41. http://dx.doi.org/10.1177/10634266050130010301
34. Walkup, J., & the American Academy of Child and Adolescent Psychiatry. (2009). Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 48, 961-973. http://dx.doi.org/10.1097/CHI.0b013e3181ae0a08
35. Wodrich, D. L., & Spencer, M. L. S. (2007). The other health impairment category and health-based classroom accommodations: School psychologists' perceptions and practices. Journal of Applied School Psychology, 24, 109-125. http://dx.doi .org/10.1300/J370v24n01_06